Intra-Cellular Therapies
ITCI
$66.84
Share price
1.72%
Change (1 day)
2.97%
Change (1 year)
Categories
Market capitalization of Intra-Cellular Therapies (ITCI)
Market cap: $7.12 Billion
As of May 2024 Intra-Cellular Therapies has a market cap of $7.12 Billion. This makes Intra-Cellular Therapies the world's 2135th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Intra-Cellular Therapies from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $7.12 B | 3.33% |
| 2023 | $6.89 B | 37.53% |
| 2022 | $5.01 B | 17.54% |
| 2021 | $4.26 B | 66.64% |
| 2020 | $2.55 B | 34.35% |
| 2019 | $1.90 B | 204.59% |
| 2018 | $0.62 B | -20.88% |
| 2017 | $0.79 B | 21.04% |
| 2016 | $0.65 B | -71.87% |
| 2015 | $2.32 B | 345.85% |
| 2014 | $0.52 B | 17.48% |
| 2013 | $0.44 B |
End of Day market cap according to different sources
On May 14th, 2024 the market cap of Intra-Cellular Therapies was reported to be:
$6.93 Billion
$6.93 Billion
$6.93 Billion
$6.93 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Xencor XNCR | $1.37 B | -80.68% | 🇺🇸 USA |
 MediciNova MNOV | $75.05 M | -98.95% | 🇺🇸 USA |
 Curis CRIS | $76.62 M | -98.92% | 🇺🇸 USA |